Central Line-associated Bloodstream Infection Prevention Using TauroLock-Hep100 in Pediatric Oncology Patients.

NCT05740150 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

462

Enrollment

OTHER

Sponsor class

Conditions

Central Line-associated Bloodstream Infection (CLABSI)

Interventions

DEVICE: TauroLock-Hep100 (taurolidine 1.35%, citrate 4%, heparin 100 IU/mL)
DEVICE: Heparin lock (heparin 100 IU/mL)

Sponsor

Princess Maxima Center for Pediatric Oncology

Collaborators

[object Object]
[object Object]